Filter News
Area of Research
- (-) Neutron Science (5)
- (-) Nuclear Science and Technology (1)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (3)
- Clean Energy (27)
- Climate and Environmental Systems (1)
- Computer Science (1)
- Materials (11)
- National Security (1)
- Quantum information Science (1)
- Supercomputing (6)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (1)
- (-) Bioenergy (2)
- (-) Biomedical (2)
- (-) Environment (3)
- Advanced Reactors (2)
- Clean Water (1)
- Composites (1)
- Computer Science (3)
- Energy Storage (2)
- Isotopes (2)
- Machine Learning (1)
- Materials Science (2)
- Molten Salt (1)
- Neutron Science (12)
- Nuclear Energy (6)
- Physics (2)
- Transportation (1)
Media Contacts
Illustration of the optimized zeolite catalyst, or NbAlS-1, which enables a highly efficient chemical reaction to create butene, a renewable source of energy, without expending high amounts of energy for the conversion. Credit: Jill Hemman, Oak Ridge National Laboratory/U.S. Dept. of Energy
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.